Young S, Le Souëf P N, Geelhoed G C, Stick S M, Turner K J, Landau L I
Department of Respiratory Medicine, Princess Margaret Hospital for Children, Perth, Australia.
N Engl J Med. 1991 Apr 25;324(17):1168-73. doi: 10.1056/NEJM199104253241704.
Airway responsiveness to inhaled nonspecific bronchoconstrictive agents has been demonstrated in normal, healthy infants. However, it is unknown whether airway responsiveness is present from birth or if it develops as a result of subsequent insults to the respiratory tract. To investigate this question, we assessed airway responsiveness in 63 normal infants at a mean age of 4 1/2 weeks.
Respiratory function was measured with use of the partial forced expiratory flow-volume technique to determine the maximal flow at functional residual capacity (VmaxFRC). The infants inhaled nebulized histamine at sequentially doubled concentrations (0.125 to 8.0 g per liter), until a concentration was reached at which the VmaxFRC fell by 40 percent from the base-line value (PC40) or until a concentration of 8.0 g per liter was reached. We also assessed maternal serum levels of IgE, cord-serum levels of IgE, the infants' skin reactivity to several allergens, and the parents' responsiveness to histamine and obtained family histories of asthma and smoking.
Airway responsiveness was increased in infants with a family history of asthma (n = 19; median PC40, 0.78 g per liter; 95 percent confidence interval, 0.44 to 1.15; P less than 0.01), parental smoking (n = 13; median PC40, 0.52 g per liter; 95 percent confidence interval, 0.43 to 5.40; P less than 0.05), or both (n = 20; median PC40, 0.69 g per liter; 95 percent confidence interval, 0.37 to 2.10; P less than 0.05), as compared with the infants with no family history of asthma or smoking. The infants with no family history of asthma or smoking had a median PC40 of 2.75 g per liter (95 percent confidence interval, 1.48 to 4.00). No significant relations were detected between the immunologic variables and the PC40 in the infants.
This study indicates that airway responsiveness can be present early in life and suggests that a family history of asthma or parental smoking contributes to elevated levels of airway responsiveness at an early age.
已证实在正常、健康的婴儿中,气道对吸入的非特异性支气管收缩剂有反应性。然而,尚不清楚气道反应性是从出生时就存在,还是由于随后呼吸道受到刺激而发展形成。为了研究这个问题,我们评估了63名平均年龄为4.5周的正常婴儿的气道反应性。
采用部分用力呼气流量-容积技术测量呼吸功能,以确定功能残气量时的最大流量(VmaxFRC)。婴儿依次吸入浓度加倍的雾化组胺(0.125至8.0微克/升),直至达到使VmaxFRC从基线值下降40%的浓度(PC40),或直至达到8.0微克/升的浓度。我们还评估了母亲血清IgE水平、脐血IgE水平、婴儿对几种过敏原的皮肤反应性、父母对组胺的反应性,并获取了哮喘和吸烟的家族史。
与无哮喘或吸烟家族史的婴儿相比,有哮喘家族史(n = 19;PC40中位数,0.78微克/升;95%置信区间,0.44至1.15;P < 0.01)、父母吸烟(n = 13;PC40中位数,0.52微克/升;95%置信区间,0.43至5.40;P < 0.05)或两者皆有的婴儿(n = 20;PC40中位数,0.69微克/升;95%置信区间,0.37至2.10;P < 0.05)气道反应性增加。无哮喘或吸烟家族史的婴儿PC40中位数为2.75微克/升(95%置信区间,1.48至4.00)。未发现婴儿的免疫变量与PC40之间存在显著关系。
本研究表明气道反应性在生命早期即可出现,并提示哮喘家族史或父母吸烟会导致儿童早期气道反应性水平升高。